ARTICLE | Clinical News
TNFalpha kinoid: Phase IIa ongoing
July 26, 2010 7:00 AM UTC
Neovacs will begin enrollment in a second dose cohort of a double-blind, placebo-controlled Phase IIa trial based on a review of safety data from the first dose cohort. The trial is evaluating RA pati...